These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 33033407)

  • 21. The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.
    Salgia R; Kulkarni P
    Trends Cancer; 2018 Feb; 4(2):110-118. PubMed ID: 29458961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Resistance in Cancers: A Free Pass for Bullying.
    Li J; Li X; Guo Q
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular Plasticity in Cancer.
    Yuan S; Norgard RJ; Stanger BZ
    Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
    Cassidy T; Nichol D; Robertson-Tessi M; Craig M; Anderson ARA
    PLoS Comput Biol; 2021 Aug; 17(8):e1009348. PubMed ID: 34460809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms.
    Braicu C; Gulei D; Raduly L; Harangus A; Rusu A; Berindan-Neagoe I
    Mol Aspects Med; 2019 Dec; 70():90-105. PubMed ID: 31703947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer invasion and resistance: interconnected processes of disease progression and therapy failure.
    Alexander S; Friedl P
    Trends Mol Med; 2012 Jan; 18(1):13-26. PubMed ID: 22177734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding resistance to targeted cancer drugs through loss of function genetic screens.
    Berns K; Bernards R
    Drug Resist Updat; 2012 Oct; 15(5-6):268-75. PubMed ID: 23142522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma.
    Roesch A; Paschen A; Landsberg J; Helfrich I; Becker JC; Schadendorf D
    Eur J Cancer; 2016 May; 59():109-112. PubMed ID: 27023049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired resistance to cancer immunotherapy.
    Draghi A; Chamberlain CA; Furness A; Donia M
    Semin Immunopathol; 2019 Jan; 41(1):31-40. PubMed ID: 29968044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.
    Foo J; Michor F
    PLoS Comput Biol; 2009 Nov; 5(11):e1000557. PubMed ID: 19893626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intricate dance of tumor evolution: Exploring immune escape, tumor migration, drug resistance, and treatment strategies.
    Guo X; Bian X; Li Y; Zhu X; Zhou X
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167098. PubMed ID: 38412927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling the effect of acquired resistance on cancer therapy outcomes.
    Masud MA; Kim JY; Kim E
    Comput Biol Med; 2023 Aug; 162():107035. PubMed ID: 37276754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal residual disease in cancer therapy--Small things make all the difference.
    Blatter S; Rottenberg S
    Drug Resist Updat; 2015; 21-22():1-10. PubMed ID: 26307504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing mutational and adaptive landscapes and the genesis of cancer.
    Liggett LA; DeGregori J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer cell metabolism: Rewiring the mitochondrial hub.
    Oliveira GL; Coelho AR; Marques R; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why therapeutic response may not prolong the life of a cancer patient: selection for oncogenic resistance.
    Blagosklonny MV
    Cell Cycle; 2005 Dec; 4(12):1693-8. PubMed ID: 16294046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unveiling the mechanisms and challenges of cancer drug resistance.
    Khan SU; Fatima K; Aisha S; Malik F
    Cell Commun Signal; 2024 Feb; 22(1):109. PubMed ID: 38347575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me'.
    Pisco AO; Huang S
    Br J Cancer; 2015 May; 112(11):1725-32. PubMed ID: 25965164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.